生物影像市场报告：2031 年趋势、预测与竞争分析

全球生物影像市场前景光明，诊所、诊断中心、医院和实验室都充满机会。预计到 2031 年，全球生物成像市场规模将达到 197 亿美元，2025 年至 2031 年的复合年增长率为 15.7%。该市场的主要驱动力是由于成像技术的进步、慢性病盛行率上升和全球人口老化、诊断中心和放射性药物的增加而对生物成像设备的需求不断增加。

• 根据 Lucintel 的预测，由于放射学在急诊医学、整形外科和普通放射学中的应用日益广泛，预计在预测期内将出现最高增长。
• 根据最终用途，医院预计仍将是最大的部分。这是由于基础设施和先进影像处理设施的显着发展，使医院能够简化营运。
• 从地区来看，北美很可能在预测期内继续保持最大地区地位，因为北美拥有完善的医疗保健体系、先进的医疗设施、不断上升的癌症和心臟疾病发病率，以及高普及率的健康保险计划，尤其是在美国。

生物成像市场的策略成长机会

在技​​术创新、更好的诊断需求和医疗技术进步的推动下，生物成像市场正在迎来新的策略成长机会。这些机会对于相关人员进入不断成长的市场和追求创新至关重要。本节概述了五个特定应用的成长机会及其在生物成像市场和未来医疗保健中的作用。

• 肿瘤成像：由于癌症发生率的不断上升，肿瘤成像成为生物成像市场的一个主要成长领域。 PET/CT、PET/MRI 和分子影像等先进影像方式正被用于准确的癌症诊断和治疗计划。人工智慧在肿瘤成像中的整合正在提高肿瘤识别的准确性并实现个人化治疗计划。这一成长机会正在吸引对先进成像解决方案开发的投资，从肿瘤学的角度扩大市场。
• 神经影像：由于阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的盛行率不断上升，神经影像也是一个主要的成长领域。功能性磁振造影 (fMRI)、扩散张量造影 (DTI) 和 PET 等新影像技术正在用于诊断和评估这些疾病。影像方式也在不断发展，以满足对病变和恶性肿瘤的快速筛检和检测日益增长的需求。这一趋势为针对神经病学的成像解决方案创造了成长机会。
• 心臟病学影像：由于心血管疾病的盛行率不断上升以及对准确诊断的需求，循环系统影像市场持续成长。使用 3D 和 4D 超音波心动图、心臟 MRI 和 CT血管造影术等先进的影像技术可以提供无需手术即可评估心臟的安全方法。基于人工智慧的工具也被整合到心臟成像系统中，以增强心臟病诊断并提高业务效率。这一市场的成长正在推动心臟影像技术的进步，从而改善患者照护。
• 整形外科影像：由于人口老化和肌肉骨骼疾病盛行率上升，整形外科影像市场正在扩大。整形外科影像技术不仅有助于诊断，还可以指南治疗计划和復健。行动影像设备在整形外科实践中特别有用，因为及时诊断和治疗性介入至关重要。这一趋势增加了对整形外科成像解决方案的需求，并刺激了先进成像技术的发展。
• 兽医影像：兽医影像学是生物影像市场成长的主要贡献者，这得益于动物保健领域对更先进诊断工具的需求。超音波、MRI 和 CT 等技术越来越多地应用于兽医诊断，为动物保健提供非侵入性解决方案。此外，人工智慧主导的兽医影像解决方案的开发正在提高诊断准确性和工作流程效率。这一成长机会为生物成像市场的扩张开闢了新的途径。

由于技术进步和对准确有效的诊断工具的需求不断增加，生物成像市场正在经历显着增长。这些趋势正在为肿瘤学、神经病学、心臟病学、骨科和兽医学等多个领域创造新的成长机会。

生物影像市场驱动因素与挑战

生物成像市场受到多种市场驱动因素和挑战的影响，包括技术进步、经济状况和监管政策。这些因素在决定市场成长、客户对成像技术的接受度以及行业的整体结构方面发挥关键作用。

驱动程式：

• 成像模式的技术改进：人工智慧、混合模式和无线成像系统等成像技术的不断改进正在推动生物成像市场的成长。这些技术创新正在提高诊断的准确性和速度，有助于市场扩张。
• 慢性病发生率上升：癌症、心血管疾病和神经系统疾病等慢性病的发生率不断上升，推动了对先进诊断影像技术的需求。快速准确诊断的需求推动了尖端成像技术的采用。
• 越来越关注标靶医疗：个人化医疗的日益增长趋势推动了对高解析度先进成像系统的需求，包括 3D 和 4D 成像。这些技术可以实现更个人化的治疗方法，进而改善患者的治疗效果。
• 增加医疗保健支出：政府和私人投资者增加医疗保健支出正在推动先进成像技术的使用。医疗设施的发展，尤其是新兴国家的医疗设施的发展，正在为成像解决方案供应商创造新的成长机会。
• 有利的监管核准和报销政策：监管核准和报销制度正在加速侵入性成像技术的采用，并鼓励对创新设备开发的投资。

任务：

• 先进影像系统高成本：先进诊断影像系统的高成本是一个重大挑战，尤其是在医疗保健预算有限的新兴国家。这一障碍阻碍了尖端成像技术的采用，减缓了市场成长。
• 资料隐私和安全问题：随着云端基础的影像处理平台和支援人工智慧的应用程式的采用率不断提高，资料隐私和安全问题也日益严重。遵守法规和保护敏感资料对于建立医疗保健提供者和患者之间的信任关係至关重要。
• 缺乏熟练的劳动力：生物成像领域缺乏熟练的专业人员，阻碍了先进成像技术的充分利用。这项挑战在缺乏操作先进影像处理系统专业知识的开发中地区尤为明显。

生物成像市场面临的驱动因素和驱动因素将塑造未来的市场趋势，并影响新技术的发展和成像服务的扩展。应对这些挑战将使相关人员能够利用市场上的新机会。

目录

第一章执行摘要

第二章全球生物影像市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球生物影像市场趋势（2019-2024）及预测（2025-2031）
• 全球生物成像市场类型
  • 弹性成像
  • 磁振造影（MRI）
  • 医学超音波/超音波
  • X射线
• 全球生物成像市场（按技术）
  • 药品
  • 分子
• 全球生物成像市场（按最终用途划分）
  • 诊所
  • 诊断中心
  • 医院
  • 研究所

第四章区域市场趋势与预测分析（2019-2031）

• 全球生物成像市场（按地区）
• 北美生物成像市场
• 欧洲生物成像市场
• 亚太生物成像市场
• 其他地区的生物成像市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球生物成像市场成长机会（按类型）
  • 全球生物成像市场成长机会（按技术）
  • 全球生物成像市场成长机会（按最终用途划分）
  • 全球生物成像市场各区域成长机会
• 全球生物成像市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球生物成像市场的生产能力
  • 全球生物成像市场的企业合併
  • 认证和许可

第七章主要企业简介

• Bioclinica
• Bracco Imaging
• FONAR
• Bayer Healthcare Pharmaceuticals
• Covidin corp
• GE Healthcare
• GammaMedica

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $19.7 billion by 2031 with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing demand for bioimaging instruments as an advancement in the imaging technologies, the rising prevalence of chronic diseases and the a aging world population, and the increasing number of diagnostic centers and radiopharmaceuticals.

• Lucintel forecasts that, within the type category, X-ray radiography is expected to witness the highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
• Within the end use category, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enable hospitals to streamline their operations.
• In terms of regions, North America will remain the largest region during the forecast period due to the presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardiac diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Bio-Imaging Market

The bio-imaging industry is undergoing significant changes driven by new trends expected to transform the market. These trends are influenced by advancements in technology, the increasing demand for reliable and rapid diagnosis, and the integration of emerging modalities with artificial intelligence (AI) and machine learning. Several general trends are emerging as the market evolves. Some of the visible trends include the adoption of hybrid imaging techniques, developments in portable imaging solutions, and the utilization of cloud-based platforms. This section highlights five key emerging trends in the bio-imaging market, focusing on their implications for access to health services, diagnostic accuracy, and market growth.

• Integration of Imaging with AI: The integration of imaging with AI is a rapidly growing trend in the bio-imaging market, leading to improved accuracy and efficiency in imaging solutions. By utilizing deep learning technologies, AI can identify shapes and contours that may be missed by the human eye, especially in detecting diseases at early stages. AI also enables real-time analysis, reducing delays in diagnostics and facilitating faster decision-making. AI imaging tools are becoming more prominent in individualized treatment planning, where treatment approaches are based on patient-specific imaging data. This trend is accelerating the development of new imaging techniques and enhancing healthcare processes.
• Overlapping Imaging Technologies: Market intelligence reports indicate that the application of overlapping imaging technologies, such as PET/MRI and SPECT/CT, is becoming increasingly important. These systems combine the advantages of multiple imaging modalities to create comprehensive central images, improving diagnostic accuracy. For example, PET/MRI combines PET imaging of metabolic changes with MRI imaging of soft tissue structures, providing both functional and anatomical insights into pathological processes. Hybrid imaging is particularly beneficial for diagnosing cancer, heart disease, and brain conditions, where understanding both the problem and its treatment is critical. This development is contributing to the emergence of more flexible and advanced imaging systems.
• Portable and Point-of-Care Imaging Devices: The demand for portable and point-of-care imaging devices is rising, particularly in rural and remote areas where healthcare facilities require portable and easy-to-use solutions. Devices like portable ultrasound and handheld MRI are enabling doctors to conduct bedside diagnostics, providing faster and more convenient care for patients. These devices are especially important in emergencies, where rapid diagnostics can save lives. Additionally, advancements in miniaturization and wireless technology are enhancing the functionality of portable imaging systems, making them an integral part of modern healthcare.
• Platforms for Imaging Hosted in the Cloud: Cloud-based imaging platforms are transforming how imaging data is captured, stored, shared, and analyzed. These platforms enable integration with electronic health records and telehealth systems, providing users with access to imaging data regardless of their location. One of the key advantages of cloud platforms is collaborative diagnostics, where multiple healthcare providers can access and interpret the same data simultaneously. These platforms also address concerns related to data ownership, security, and access, making them a critical trend in the bio-imaging industry. As data privacy and security issues are resolved, this trend is expected to grow.
• Precision Oncology as a Course of Action in Theragnostic Research and Molecular Imaging: Molecular imaging and theragnostics are becoming increasingly important in oncology. These technologies enable imaging of both anatomical and pathological processes in the body, highlighting changes that can guide treatment decisions. The use of theragnostic agents, which combine diagnostic and therapeutic functions, is leading to more personalized treatments. The growing use of PET/CT and PET/MRI as molecular imaging techniques is facilitating the development of improved targeted radiopharmaceuticals for both diagnostic and therapeutic purposes.

The trends observed in the bio-imaging sector are transforming how healthcare services are delivered by increasing diagnostic and treatment efficiency, reducing costs, and enhancing patient satisfaction. These trends play a key role in driving the growth and advancement of the market, opening up new opportunities for market players.

Recent Developments in the Bio-Imaging Market

The bio-imaging market is undergoing significant changes that are reshaping its structure. Key developments include the integration of new imaging systems with AI, as well as strategic partnerships that are boosting market progress. The entry of miniaturized imaging devices, networked applications, and novel imaging modalities is enabling more accurate and timely diagnoses. These improvements are essential for the healthcare system, ensuring better patient care, streamlining processes, and supporting targeted treatments. This section focuses on five key areas of growth within the bio-imaging industry.

• AI-Based Imaging Tools: New AI-based imaging tools are making diagnoses more effective and expediting analysis in the bio-imaging industry. These tools use algorithms and data analysis to enhance the screening process for various diseases. AI-enhanced imaging devices are also helping develop patient-specific treatment plans, particularly for cancer and neurological diseases. This growing use of modern imaging technologies is creating a market for AI-powered bio-imaging solutions.
• Introduction of Cloud-Based Imaging Platforms: The introduction of cloud-based imaging platforms is a significant development in the bio-imaging industry. These platforms enable the secure storage, sharing, and analysis of imaging data, fostering collaboration among healthcare providers. Remote access to imaging data is particularly important for telemedicine and remote diagnostics. These platforms also address challenges related to data storage and management, offering solutions that meet the needs of users while accommodating increasing volumes of digital health tools.
• Introduction of Hybrid Imaging Systems: Hybrid imaging systems, such as PET/CT, PET/MRI, and SPECT/CT, combine multiple imaging modalities to provide a more comprehensive view of the body. The information from these systems is integrated to deliver both anatomical and functional insights, enhancing diagnostic accuracy. Hybrid imaging is particularly useful in oncology, cardiology, and neurology, where diagnostic precision is critical. The next generation of hybrid imaging systems is expected to bring further innovation and market expansion.
• Collaboration and Strategic Partnerships: Innovation in the bio-imaging market is being driven by collaboration and strategic partnerships between key players, including medical device companies, research institutions, and service providers. These partnerships are helping to accelerate the development and adoption of new imaging technologies.

Recent developments in bio-imaging, such as improvements in non-invasive probes, are enhancing the capabilities of imaging systems, improving patient treatment, and driving market growth. These developments are creating favorable conditions for stakeholders and offering new opportunities within the healthcare sector.

Strategic Growth Opportunities for Bio-Imaging Market

The bio-imaging market is identifying new strategic growth opportunities, driven by technological innovation, the demand for better diagnosis, and advancements in healthcare technology. These opportunities are crucial for stakeholders entering the growing market and pursuing innovations. This section outlines five growth opportunities by application and their roles in the bio-imaging market and the future of healthcare.

• Oncology Imaging: Oncology imaging is a major growth segment in the bio-imaging market due to the increasing incidence of cancer. Advanced imaging devices such as PET/CT, PET/MRI, and molecular imaging are used for accurate cancer diagnosis and treatment planning. The integration of AI in oncology imaging is improving the precision of tumor identification and enabling personalized treatment plans. This growth opportunity is attracting investment in the development of advanced imaging solutions, expanding the market from an oncology perspective.
• Neurology Imaging: Neurology imaging is another key growth segment due to the rising prevalence of neurological conditions such as Alzheimer's, Parkinson's disease, and multiple sclerosis. New imaging techniques, including functional MRI (fMRI), diffusion tensor imaging (DTI), and PET, are being used to diagnose and assess these diseases. Imaging methods are also evolving to meet the growing demand for rapid screening and detection of lesions and malignancies. This trend is creating growth opportunities for imaging solutions targeting neurology.
• Cardiology Imaging: The cardiology imaging market continues to grow due to the increasing incidence of cardiovascular diseases and the need for accurate diagnosis. The use of advanced imaging techniques such as 3D and 4D echocardiography, cardiac MRI, and CT angiography is providing safer ways to assess the heart without surgery. AI-based tools are also being integrated into cardiology imaging systems to enhance the diagnosis of heart diseases and improve operational efficiency. This market growth is spurring advances in cardiac imaging technologies, improving patient care.
• Orthopedic Imaging: The orthopedic imaging market is expanding due to the aging population and the rising prevalence of musculoskeletal disorders. Imaging techniques in orthopedics are not only helping with diagnosis but also guiding treatment planning and rehabilitation. Mobile imaging devices are particularly valuable in orthopedic practices, where timely diagnostics and therapeutic interventions are critical. This trend is increasing the demand for orthopedic imaging solutions and driving the development of advanced imaging techniques.
• Veterinary Imaging: Veterinary imaging is emerging as a key contributor to the growth of the bio-imaging market, driven by the demand for more sophisticated diagnostic tools in the animal health sector. Techniques such as ultrasound, MRI, and CT are increasingly being used for veterinary diagnostics, offering non-invasive solutions for animal care. Additionally, the development of AI-driven imaging solutions for veterinary care is enhancing diagnostic accuracy and workflow efficiency. This growth opportunity is unlocking new avenues for expansion in the bio-imaging market.

The bio-imaging market is experiencing significant growth due to advancements in technology and the increasing demand for accurate and effective diagnostic tools. These trends are creating new growth opportunities in various sectors, including oncology, neurology, cardiology, orthopedics, and veterinary care.

Bio-Imaging Market Driver and Challenges

The bio-imaging market is influenced by several drivers and challenges, including technological advancements, economic conditions, and regulatory policies. These factors play a crucial role in determining market growth, customer acceptance of imaging technologies, and the overall structure of the industry.

Drivers:

• Technological Improvements in Imaging Modalities: Continuous improvements in imaging technologies, such as the integration of AI, hybrid modalities, and wireless imaging systems, are driving growth in the bio-imaging market. These innovations are improving diagnostic accuracy and speed, contributing to market expansion.
• Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological conditions, is increasing the demand for advanced imaging techniques. The need for swift and accurate diagnosis is driving the adoption of state-of-the-art imaging technologies.
• Increased Interest in Targeted Medicine: The growing trend of personalized medicine is driving demand for advanced imaging systems with high resolution, such as 3D and 4D imaging. These technologies are enabling more tailored therapeutic approaches, leading to better patient outcomes.
• Increase in Health Expenditure: Rising healthcare spending from both national governments and private investors is promoting the use of advanced imaging techniques. The improvement of healthcare facilities, especially in developing countries, is opening new growth opportunities for imaging solution providers.
• Favorable Regulatory Approvals and Reimbursement Policies: Regulatory approvals and reimbursement schemes are facilitating the adoption of invasive imaging technologies and encouraging investment in innovative equipment development.

Challenges:

• High Cost of Advanced Imaging Systems: The high cost of advanced imaging systems is a major challenge, especially in developing countries with limited medical budgets. This barrier reduces the adoption of cutting-edge imaging technologies, slowing market growth.
• Concerns About Data Privacy and Security: The increased adoption of cloud-based imaging platforms and AI-powered applications has raised concerns about data privacy and security. Ensuring compliance with regulations and protecting sensitive data is critical to building trust among healthcare providers and patients.
• Shortage of Skilled Workforce: A shortage of skilled professionals in the bio-imaging sector is preventing the full utilization of advanced imaging technologies. This challenge is particularly prevalent in developing regions, where expertise in operating sophisticated imaging systems is limited.

The drivers and challenges facing the bio-imaging market will shape its future trends, influencing the development of new technologies and the expansion of imaging services. Addressing these challenges will help stakeholders leverage emerging opportunities in the market.

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

• Bioclinica
• Bracco Imaging
• Fonar
• Bayer Healthcare Pharmaceuticals
• Covidin
• GE Healthcare
• Gammamedica

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging market by type, technology, end use, and region.

Bio-Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Elastography
• Magnetic Resonance Imaging
• Medical Ultrasonography or Ultrasound
• X-Ray Radiography

Bio-Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Medical
• Molecular

Bio-Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Clinics
• Diagnostic Centers
• Hospitals
• Laboratories

Bio-Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Imaging Market

The global bio-imaging market is undergoing significant advancements due to technological innovations, increased healthcare spending, and the rising demand for accurate diagnosis. Countries such as the United States, China, Germany, India, and Japan are at the forefront of these developments, each contributing distinct advancements that will impact the global market. Key trends include the introduction of AI, the exploration of new imaging modalities, and the formation of alliances among industry players. This section summarizes the developments in each of these countries, highlighting key trends and advancements in the bio-imaging sector.

• United States: The bio-imaging market in the United States is rapidly evolving, with a strong focus on integrating AI into imaging technologies. Partnerships between companies and research institutions are driving innovation, especially in the early diagnosis of diseases like cancer and neurological disorders. The U.S. FDA's approval of new imaging devices has improved diagnostic capabilities, while public interest in personalized medicine is pushing the demand for modern 3D and 4D imaging systems. Additionally, there is growing interest in cloud-based solutions for remote diagnostics.
• China: China's bio-imaging market is growing quickly, fueled by expanding healthcare infrastructure and a focus on local innovation. The country is adopting advanced imaging techniques, including molecular imaging and AI-based diagnostic tools. Chinese companies are forming alliances with international firms to enhance technological capabilities. Government policies supporting medical device innovation have led to the production of cost-effective yet sophisticated imaging systems. An aging population and the rising incidence of chronic diseases are further driving the demand for bio-imaging solutions.
• Germany: Germany continues to be a leader in the bio-imaging market, benefiting from its high-quality healthcare system and innovative developments. Recent advancements include the use of computer-aided detection (CAD) and image analysis (IA) systems to improve diagnostic performance. The adoption of hybrid imaging systems, such as PET/MRI and SPECT/CT, is also on the rise. Collaboration between hospitals, research institutions, and companies is fostering innovation, particularly in precision medicine for cancer and neurological diseases.
• India: India is experiencing steady growth in the bio-imaging market, with a focus on cost-effective and high-quality imaging solutions. The demand for imaging tools is increasing in rural areas, where remote diagnostics and AI-powered systems are playing a significant role. Government initiatives, such as the "Make in India" program, are promoting the development of homegrown bio-imaging technologies, making them more affordable and accessible. Public-private partnerships are also helping expand the availability of advanced imaging systems across the country.
• Japan: Japan's bio-imaging market is advancing rapidly, with a strong emphasis on new technologies such as 4D MRI and high-frequency ultrasound for better diagnostic imaging. The government is actively supporting the development of advanced imaging systems, and portable imaging devices combined with AI are becoming increasingly popular, especially for elderly care. Research on the longitudinal adoption of these technologies is also underway, with a focus on early diagnosis and patient comfort.

Features of the Global Bio-Imaging Market

Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the bio-imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bio-Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bio-Imaging Market by Type
  • 3.3.1: Elastography
  • 3.3.2: Magnetic Resonance Imaging
  • 3.3.3: Medical Ultrasonography or Ultrasound
  • 3.3.4: X-ray Radiography
• 3.4: Global Bio-Imaging Market by Technology
  • 3.4.1: Medical
  • 3.4.2: Molecular
• 3.5: Global Bio-Imaging Market by End Use
  • 3.5.1: Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Hospitals
  • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bio-Imaging Market by Region
• 4.2: North American Bio-Imaging Market
  • 4.2.1: North American Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.2.2: North American Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.3: European Bio-Imaging Market
  • 4.3.1: European Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.3.2: European Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.4: APAC Bio-Imaging Market
  • 4.4.1: APAC Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.4.2: APAC Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.5: ROW Bio-Imaging Market
  • 4.5.1: ROW Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.5.2: ROW Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
  • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
• 6.2: Emerging Trends in the Global Bio-Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bioclinica
• 7.2: Bracco Imaging
• 7.3: FONAR
• 7.4: Bayer Healthcare Pharmaceuticals
• 7.5: Covidin corp
• 7.6: GE Healthcare
• 7.7: GammaMedica